| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -67.3% | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 21.6 | n/a |
| Pr/Book | 2.1 |
| Latest | F'cast | |
|---|---|---|
| Revenue | n/a | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-21 | n/a | (24.69) | (14.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | n/a | (21.90) | (11.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | n/a | (0.83) | (0.30)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | n/a | (23.46) | (7.10)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-25 | 26.98 | (18.60) | (4.40)¢ | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
No recent information was found.
| Amaroq delisting from TSX-V to take effect | 19-Mar-2026 | ShareCast |
| Amaroq sets out fresh production guidance | 25-Feb-2026 | ShareCast |
| HealthMark Group Expands Digital Access to Medic... | 12-Feb-2026 | ShareCast |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 97.00p |
| Change Today | -1.50p |
| % Change | -1.52 % |
| 52 Week High | 149.00 |
| 52 Week Low | 63.00 |
| Volume | 387,127 |
| Shares Issued | 465.44m |
| Market Cap | £451.48m |
| Beta | 0.00 |
| Value | ![]() |
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:36 | 85,000 @ 97.00p |
| 16:35 | 35,483 @ 97.00p |
| 16:35 | 424 @ 97.00p |
| 16:35 | 159 @ 97.00p |
| 16:35 | 25,000 @ 97.00p |
| CEO | Eldur Ólafsson |
| CFO | Ellert Arnarson |
You are here: research